CoChat

The Effect of Tobacco Smoking on Bone Mass: An Overview of Pathophysiologic Mechanisms

Open access
Al-Bashaireh, Ahmad M., Haddad, Linda G., Weaver, Michael, Chengguo, Xing, Kelly, Debra Lynch, Yoon, Saunjoo · 2018 · Journal of Osteoporosis

The DOI matches its Crossref record; 96 of the 99 references it cites were found in a registry or an index; 32 of the 142 sources its claims cite were checked for support.

Abstract

Recent evidence demonstrates that tobacco smoking causes an imbalance in bone turnover, leading to lower bone mass and making bone vulnerable to osteoporosis and fracture. Tobacco smoke influences bone mass indirectly through alteration of body weight, parathyroid hormone-vitamin D axis, adrenal hormones, sex hormones, and increased oxidative stress on bony tissues. Also, tobacco smoke influences bone mass through a direct effect on osteogenesis and angiogenesis of bone. A RANKL-RANK-OPG pathway is an essential regulatory pathway for bone metabolism and its importance lies in its interaction with most of the pathophysiologic mechanisms by which smoking influences bone mass. Both first- and secondhand smoke adversely affect bone mass; smoking cessation seems to reverse the effect of smoking and improve bone health. Recent advances in research on bone turnover markers could advance scientific knowledge regarding the mechanisms by which smoking may influence bone mass.

Overview

CoChat Summary

TL;DR

This narrative review summarizes direct and indirect pathophysiologic mechanisms by which tobacco smoking reduces bone mass and increases osteoporosis and fracture risk, with the RANKL-RANK-OPG pathway as a central mediator. It also reviews secondhand smoke and smoking cessation effects, concluding that the mechanisms are complex and require further research.

Key findings

  • Tobacco smoking causes an imbalance in bone turnover, leading to lower bone mass and BMD and greater vulnerability to osteoporosis and fracture; the Surgeon General causally linked smoking with skeletal disorders including hip fracture, rheumatoid arthritis, and periodontitis.
  • Indirect mechanisms include lower body weight/BMI, altered PTH-vitamin D axis and calcium absorption, increased cortisol and adrenal androgens, altered sex hormones (including lower estradiol and menopause about two years earlier in women who smoke), and increased oxidative stress; smokers had lower antioxidant enzymes and higher oxidative stress products, and smokers with low intake of vitamins C and E had a fivefold increased risk of hip fracture compared with nonsmokers.
  • Direct effects involve nicotine and polycyclic aryl hydrocarbons on osteoblasts/osteoclasts and angiogenesis; the RANKL-RANK-OPG pathway interacts with most indirect mechanisms. Smoke-exposed rats had higher RANKL/OPG ratios, and human smokers generally had lower OPG and higher RANKL/OPG ratios, though one study found lower RANKL and higher RANKL/OPG ratio in smokers that were not statistically significant.
  • Secondhand smoke adversely affects bone: exposed subjects had significantly lower phalangeal BMD (p < 0.01) and higher risk for femoral neck osteoporosis (OR 3.68; 95% CI 1.23–10.92). Smoking cessation may reverse effects, with bone density improvement in less than 10 years and, in postmenopausal women, improvement in gonadal hormones and bone formation/resorption markers in 6 weeks and bone density after 1 year.

Methods

  • Narrative overview/review with three aims: summarize pathophysiologic mechanisms of tobacco smoke on bone mass, discuss interactions with the RANKL-RANK-OPG pathway and bone turnover markers, and understand secondhand smoke and smoking cessation effects.
  • No primary data collection or systematic search strategy is described; the paper synthesizes prior reviews, laboratory animal/cell studies, and human observational studies.
  • Main analysis is a qualitative synthesis organized into indirect mechanisms, direct bone tissue effects, confounding factors, secondhand smoke, and smoking cessation.

Limitations

  • The paper states that pathophysiologic mechanisms remain unclear because there are few appropriately designed studies to clarify mechanisms and some findings are contradictory; further research is needed.
  • The paper notes that few studies have explored the relationship between smoking and the RANKL-RANK-OPG pathway and bone turnover markers in humans, and that the finding of lower RANKL in smokers was unexpected and may be affected by factors other than smoking.
  • Evident from the text: as a narrative review without a described systematic search or meta-analysis, conclusions depend on selected literature, and many cited mechanistic findings come from animal/cell models and observational human studies, limiting causal inference.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.1155/2018/1206235

Cites

96 of 96 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Figures

Figure 1 Potential pathophysiologic mechanisms of decreased bone mass in tobacco smokers. PTH: parathyroid hormone; 25-OH-D: 25-hydroxy vitamin D; 1, 25-OH2-D: 1, 25 dihydroxyvitamin D; RANKL: Receptor Activator of Nuclear Factor-Kappa B Ligand; OPG: Osteoprotegerin.
Figure 1 Potential pathophysiologic mechanisms of decreased bone mass in tobacco smokers. PTH: parathyroid hormone; 25-OH-D: 25-hydroxy vitamin D; 1, 25-OH2-D: 1, 25 dihydroxyvitamin D; RANKL: Receptor Activator of Nuclear Factor-Kappa B Ligand; OPG: Osteoprotegerin.CC BY · PubMed Central

Verification

Claims the paper makes

26 Valid · 2 Not valid · 50 Not checked · 13 Own results and interpretations

27 more claims · 3 with their cited sources checked

Create a free account to see all 91 claims and every source verdict.

See all claims — free account
  • It may state two separate claims as one. 47
  • Probably not a substantial claim. 21

Create a free account to see these claims.

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

Each contradiction between two passages listed here was confirmed by an independent check.

2 of 2

Citations

Cites

Research works printed but not linked: 7

  1. 2001, Morbidity and Mortality Weekly Report (MMWR), 60, 1513
  2. 2013, Muscles, Ligaments and Tendons Journal, 3, 63
  3. 2016, Acta Medica Mediterranea, 32, 317
  4. 2015, Hormones, 14, 245
  5. 2009, Turkiye Klinikleri Journal of Medical Sciences, 29, 851
  6. 2011, Acta Reumatologica Portuguesa, 36
  7. 2006, The cells of bone

Cited by

See all 214

Metadata

Authors
Al-Bashaireh, A. M., Haddad, L. G., Weaver, M., Chengguo, X., Kelly, D. L., & Yoon, S.
Affiliations
  • University of Florida (US)
  • University of North Carolina Wilmington (US)
  • Professor, College of Pharmacy, University of Florida, Gainesville, FL, USA
Corresponding author
Al-Bashaireh, Ahmad M.
Venue
Journal of Osteoporosis
Publisher
Wiley
Published
2018-12-02
Volume
2018
Pages
1-17
ISSN
  • 2042-0064 (ISSN-L)
  • 2090-8059
OpenAlex
W2903346619
Cited by
209
References
99
Citations by year
2026: 24 · 2025: 27 · 2024: 32 · 2023: 46 · 2022: 26 · 2021: 29 · 2020: 18 · 2019: 7
FWCI
2.77
Type
journal article
Language
en
Open access
Locations
  • Journal of Osteoporosis (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
University of Florida
Topics
  • Health Sciences › Medicine › Orthopedics and Sports Medicine › Bone health and osteoporosis research
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Bone Metabolism and Diseases
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Smoking Behavior and Cessation
Keywords
smoking, bone mass, osteoporosis, bone turnover, RANK/RANKL/OPG pathway, sex hormones, adrenal hormones, oxidative stress, bone formation, angiogenesis, passive smoking, smoking cessation, bone turnover markers

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

The claim verdicts this report counts are experimental: their accuracy is not yet measured.

A language model drew the claims from the paper on 2026-09-30, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-09-30 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Cited sources are checked with a language model’s help (gpt-6-sol).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.